Overview
- The voluntary action, expanded on Dec. 16, broadened an earlier single-lot recall to cover every lot of both homeopathic sprays nationwide.
- All units within expiration dates from December 2022 through December 2025 are affected, with 20 mL bottles sold online and through retailers.
- The FDA urges immediate discontinuation, with refunds available by emailing recall@medinatura.com or by returning products to the point of purchase.
- MediNatura reports no adverse events so far, though regulators caution there is a reasonable probability of serious, potentially life‑threatening infections in people with weakened immune systems.
- Product identifiers include ReBoost NDC 62795-4005-9 (UPC 787647101863) and ClearLife NDC 62795-4006-9 (UPC 787647101887), and Hawaii health officials advise watching for fever, sinus swelling, facial pain, headaches, or facial numbness.